Sign in

CIK 0001689375

  • Accelerated filer
  • Smaller reporting company
  • Emerging growth company

Entrada Therapeutics, Inc.

Sign in to watch
Ticker
TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813983399
Phone
+1 857-305-1825
Business address
ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
Former names
CycloPorters, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,200,939
in 8 filings

Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 21 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-09-21 Dowden Nathan J Chief Operating Officer Sale −3,275 $15.13 $50K 65,373
2022-09-15 Doshi Dipal President and CEO Sale −200 $15.04 $3K 219,847
2022-09-15 Dowden Nathan J Chief Operating Officer Sale −100 $15.01 $2K 68,648
2022-09-15 KREHER NERISSA Chief Medical Officer Option exercise +106 $2.10 $223 20,822
2022-09-15 KREHER NERISSA Chief Medical Officer Sale −106 $15.01 $2K 20,716
2022-09-15 KREHER NERISSA Chief Medical Officer Option exercise · Stock Option (Right to Buy) −106 28,905
2022-09-09 Doshi Dipal President and CEO Sale −688 $15.07 $10K 220,047
2022-09-09 KREHER NERISSA Chief Medical Officer Option exercise +800 $2.10 $2K 21,516
2022-09-09 KREHER NERISSA Chief Medical Officer Sale −800 $15.07 $12K 20,716
2022-09-09 KREHER NERISSA Chief Medical Officer Option exercise · Stock Option (Right to Buy) −800 29,011
2022-09-09 Dowden Nathan J Chief Operating Officer Sale −865 $15.06 $13K 68,748
2022-09-08 Doshi Dipal President and CEO Sale −1,100 $15.16 $17K 220,735
2022-09-08 KREHER NERISSA Chief Medical Officer Option exercise +1,221 $2.10 $3K 21,937
2022-09-08 KREHER NERISSA Chief Medical Officer Sale −1,221 $15.13 $18K 20,716
2022-09-08 KREHER NERISSA Chief Medical Officer Option exercise · Stock Option (Right to Buy) −1,221 29,811
2022-09-08 Dowden Nathan J Chief Operating Officer Sale −912 $15.15 $14K 69,613
2022-09-01 WENTWORTH KORY JAMES Chief Financial Officer Grant or award +5,503 16,489
2022-09-01 Sethuraman Natarajan Chief Scientific Officer Grant or award +5,794 162,144
2022-09-01 KREHER NERISSA Chief Medical Officer Grant or award +5,172 20,716
2022-09-01 Dowden Nathan J Chief Operating Officer Grant or award +5,632 70,525

Page 22 of 26 · 517 trades